Hints and tips:
Related Special Reports
...AstraZeneca’s research and development budget under Soriot, the successful launch of many blockbuster drugs and the expansion of the business into rare diseases, vaccines and immunology, Jain said: “I’d...
...He set aside £520mn in his November Autumn Statement to “build resilience for future health emergencies and capitalise on the UK’s R&D strengths”....
...But analysts at Jefferies said that worries about the company’s “R&D productivity will take time to lift”, pointing to a lack of significant trial results expected in 2024 and growth tailing off for the...
...She urged countries and the pharmaceutical sector to boost funding to tackle nine other high-risk pathogens identified as threats by the WHO....
...The UK-based pharmaceutical group reported revenue of $12.7bn for the first quarter of 2024, an increase of 19 per cent, well ahead of consensus estimates of $11.9bn....
...Investors will require that his commitment to R&D actually leads to wins....
...the first pharmaceutical treatment for the underlying disease,” said Emmick....
...“I used to forget the tiniest everyday things: I’d put eggs on to boil, I’d forget. Papers were stacked four feet high on my desk,” said Davis, 74....
...According to the European Federation of Pharmaceutical Industries and Associations, a Brussels-based lobby group, the US attracted a third more R&D investment than Europe in 2010....
...“I think something that I should have explained better at earnings was that almost all of the increase in investment in R&D is in D. Because that’s where the action is for us....
...These data reinforce that message,” said Susan Galbraith, executive vice-president of oncology R&D at AstraZeneca....
...“We are poised to become a leader in immuno-dermatology, with a broad pipeline including 14 active R&D programmes.”...
...In an ideal world we’d like everyone to have access” and credit, he said. Time to reach consensus and to keep the pandemic treaty alive was running out, observers said....
...He argued that the size of an R&D budget was not an automatic guarantee of success. “Two of the companies that had the lowest R&D spending a decade ago were Eli Lilly and Novo Nordisk....
...Pharmaceutical companies must replenish their drugs pipeline before exclusivity rights on top-selling products expire....
...Shares in Sanofi fell 19 per cent on Friday after the French pharmaceutical group announced a lower profit outlook and a spinout of its consumer care unit as it seeks to focus on drug research....
...The R&D is alive and well there.” Truckenmiller said the vaccine’s US launch should soothe concerns about the company’s broader pipeline of drugs....
...Novo’s next generation drug CagriSema is biopharma’s most valuable R&D project, with a net present value of $30bn, according to Evaluate....
...We need to revive the antibiotics R&D pipeline, to ensure that we continue to obtain new and effective antibiotics in the face of the spread and growth of drug-resistant bugs....
...The report predicts the EU’s share of global R&D investment, already falling, would reduce by a third by 2040, from 32 per cent to 21 per cent....
...Niamh Brennan, founder of the University College Dublin Centre for Corporate Governance, dismissed the response as “weasel words”, adding: “I’d say GSK doesn’t apply its own standards to itself.”...
...So it’d be really interesting to see whether that changes the game for some health systems. Michela Tindera Mmm....
...He said Lilly had benefited from its strong research culture and breakthroughs in the two biggest untapped pharmaceutical markets....
...He founded and later sold the companies Pharmaceutical Product Development, a contract research organisation, and Furiex Pharmaceuticals, whose leading product was a diarrhoea medication....
...BF Borgers’ client list spans far and wide, including several tiny Chinese companies that seem to specialise in everything from pharmaceuticals to vaping....
International Edition